Study population patients diagnosed with hormone receptor positive HER2 negative metastatic breast cancer from 2012 to 2018 who received everolimus exemestane in first line, second line, or third line generic cialis 20mg Other both TAM and AIs may result in eye symptoms, headache, fatigue, GI symptoms, psychiatric conditions, and cognitive dysfunction there was no significant difference in the incidence of these adverse effects reported